These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 30884251)

  • 1. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?
    Theoharides TC; Tsilioni I; Ren H
    Expert Rev Clin Immunol; 2019 Jun; 15(6):639-656. PubMed ID: 30884251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of mast cell activation disorders.
    Petra AI; Panagiotidou S; Stewart JM; Conti P; Theoharides TC
    Expert Rev Clin Immunol; 2014 Jun; 10(6):729-39. PubMed ID: 24784142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell activation: beyond histamine and tryptase.
    Theoharides TC; Perlman AI; Twahir A; Kempuraj D
    Expert Rev Clin Immunol; 2023 Jun; 19(6):639-654. PubMed ID: 37029958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases.
    Theoharides TC; Tsilioni I
    Curr Top Med Chem; 2018; 18(21):1872-1882. PubMed ID: 30451113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
    Picard M; Giavina-Bianchi P; Mezzano V; Castells M
    Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-onset mast cell activation syndrome following scombroid poisoning: a case report and review of the literature.
    Brock I; Eng N; Maitland A
    J Med Case Rep; 2021 Dec; 15(1):620. PubMed ID: 34920756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation.
    Butterfield JH
    Int Arch Allergy Immunol; 2020; 181(1):43-50. PubMed ID: 31722348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
    Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
    Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli.
    Vasiadi M; Kalogeromitros D; Kempuraj D; Clemons A; Zhang B; Chliva C; Makris M; Wolfberg A; House M; Theoharides TC
    Int Arch Allergy Immunol; 2010; 151(1):38-45. PubMed ID: 19672095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
    Ravi A; Butterfield J; Weiler CR
    J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast Cell Activation Syndrome.
    Frieri M
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):353-365. PubMed ID: 25944644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent Effects of Acute and Prolonged Interleukin 33 Exposure on Mast Cell IgE-Mediated Functions.
    Rönnberg E; Ghaib A; Ceriol C; Enoksson M; Arock M; Säfholm J; Ekoff M; Nilsson G
    Front Immunol; 2019; 10():1361. PubMed ID: 31275312
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders.
    Muñoz-González JI; García-Montero AC; Orfao A; Álvarez-Twose I
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):427-434. PubMed ID: 34298172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective, α2β1 integrin-dependent secretion of il-6 by connective tissue mast cells.
    McCall-Culbreath KD; Li Z; Zhang Z; Lu LX; Orear L; Zutter MM
    J Innate Immun; 2011; 3(5):459-70. PubMed ID: 21502744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.
    Jackson CW; Pratt CM; Rupprecht CP; Pattanaik D; Krishnaswamy G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and Pathology of Mastocytosis.
    Metcalfe DD; Mekori YA
    Annu Rev Pathol; 2017 Jan; 12():487-514. PubMed ID: 28135563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
    Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P
    Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
    Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
    Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of Monocyte Chemoattractant Protein-1 by Tryptase Co-Released in Immunoglobulin E-Dependent Activation of Primary Human Cultured Mast Cells.
    Tam IYS; Ng CW; Lau HYA; Tam SY
    Int Arch Allergy Immunol; 2018; 177(3):199-206. PubMed ID: 30021208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.